Journey Medical (DERM)
(Delayed Data from NSDQ)
$4.83 USD
+0.32 (7.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.87 +0.04 (0.83%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (96 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.59 | 9.99 |
Current Quarter Estimate | -0.17 | -1.21 | 61.00 |
Year Ago Quarter Estimate | 0.80 | -0.07 | 54.84 |
Next Quarter Estimate | -0.18 | -1.90 | 63.00 |
Next Year Estimate | -0.13 | 12.55 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -400.00 | 19.70 | 15.67 |
Next Year | 87.62 | 15.20 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 22.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.96 |
Price/Book (MRQ) | 8.56 | 1.54 |
Price/Cash Flow (MRFY) | 26.66 | 8.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 1.09% | -61.35% |
Return on Equity (TTM) | 5.44% | -58.93% |
Debt to Equity (MRQ) | 1.75 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.